Articles

Podcasts

Videos

Geriatrics

Geriatric medicine condition center page is a comprehensive resource for clinical news and insights on frequent geriatric-related diseases and conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for sleep disorder, dementia, Alzheimer's disease, and more.

Patients included in the high-dose group demonstrated statistically significant improvements compared to placebo for MDS-UPDRS total score.

Blarcamesine Improves Symptoms for Patients with Parkinson Disease Dementia

Genetically-indexed inhibition of TNF-TNFR1 signaling was predicted to reduce the risk of Crohn’s disease and ulcerative colitis, and increased the risk of multiple sclerosis.

TNF Treatment Fails to Prevent or Delay Parkinson Disease in Clinical Trial

History of syncope was present in 17% of the Parkinson group who had an altered blood pressure regulation upon standing and in 10% of those without.

Transient Orthostatic Hypotension Commonly Found in Parkinson Disease

Considerable discrepancy found between overt clinical symptoms of laryngeal pathology and abnormalities observed during a task protocol.

Laryngeal Movement Disorders Distinguish MSA from Parkinson Disease

The Patient Controller will join a growing list of Abbott digital care products aimed at streamlining the therapeutic experience.

FDA Approves Personalized Chronic Pain Therapy Mobile Application

The new approval is based on the result of 38 clinical trials involving more than 1000 patients.

FDA Approves Opicapone to Increase Parkinson Disease ON Time

Impulse control disorder symptoms also commonly found in Parkinson disease patients treated with dopamine agonists.

Parkinson Disease Dementia Linked to Compulsive Behaviors

Study data suggested that up to 80% of patients with Parkinson disease may have ophthalmologic symptoms.

Vision Problems More Common in Patients with Parkinson Disease

New drug more often linked to a full ON response from Parkinson disease patients at 30 minutes when compared to a placebo.

Apomorphine Helps Increase On Time Response for Parkinson Disease Patients

Patients in the treatment group had improved dyskinesia symptoms and off time.

Extended-Release Amantadine Reduces Dyskinesia in Parkinson Disease Patients

The HCPLive Parkinson's disease page is a comprehensive resource for clinical news and insights on PD. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for movement disorders, and more.